21 May 2009
Posttransplant encapsulating peritoneal sclerosis – one centre experience
A Dębska-Ślizień, B Januszko-Giergielewicz, J Konopa, W Wołyniec, A Chamienia, B RutkowskiAnn Transplant 2009; 14(1): 53-53 :: ID: 880392
Abstract
Background: Encapsulating peritoneal sclerosis (EPS) is rare but serious
complication in patients on peritoneal dialysis (PD). It is defined as intermittent or recurrent intestinal obstruction with or without signs of inflammation and the existence of peritoneal thickening, sclerosis, calcifications and encapsulation. Aim: We describe 4 post-transplant EPS cases occurring in our centre.
Material/Methods: From December 1994 to December 2008, some 69 PD patients received kidney transplantation (KT) and 4 of them (3 m, 1 f) developed EPS. Mean age of all PD patients was 39.9±12.4 and those with EPS 48.3 (range 42-59) years. RRT duration time of all PD patients was 19.7 (range 1-93) months, while patients with EPS 103.8 (range 56-192) months. EPS patients were maintained on PD for 71.3 (range 56-89) months. All required high volume dialysis to achieve its adequacy (APD), two received icodextrin, all but one were high transporters, one had returning intrperitoneal bleeding, all received beta-blockers, all had peritonitis incidents (1-2).
Results: Described patients developed severe symptoms of intestinal obstruction, and required surgical intervention within 1-3 months after KT. Diagnosis was based on: clinical symptoms, macroscopic inspection, radiological and histopathological findings. Treatment consisted of: adhesiolysis, parenteral nutrition (PN) (2/4) and tamoxifen. 49 months since EPS diagnosis and after 27 months of PN one patient died. The other live with well functioning grafts (19, 20 and 23 months after KT); one is still on PN, all receive tamoxifen, steroids, tacrolimus and mycophenolate mofetil. Conclusions: EPS should be considered when bowel obstructive symptoms appear in a long term PD patients undergoing KT. These patients may take advantage from such therapeutic measures as adhesiolysis, chronic PN and tamoxifen. Early enrolment to transplantation waiting list should be considered in all suitable PD patients.
Keywords: Kidney Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860